Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 129,423 | 99,597 | 83,570 | 72,050 | 67,449 |
| Cost of Goods | 46,234 | 38,011 | 32,790 | 29,253 | 25,959 |
| Gross Profit | 83,189 | 61,586 | 50,780 | 42,797 | 41,490 |
| Operating Expenses | 67,144 | 53,871 | 57,169 | 61,678 | 69,522 |
| Operating Income | 16,279 | 7,726 | -5,599 | -18,628 | -27,073 |
| Interest Expense | 0 | 0 | 0 | 0 | 55 |
| Other Income | 1,913 | 1,129 | 661 | 2,088 | 0 |
| Pre-tax Income | 18,192 | 8,855 | -4,938 | -16,540 | -27,128 |
| Income Tax | 810 | 305 | 0 | N/A | N/A |
| Net Income Continuous | 17,382 | 8,550 | -4,938 | -16,540 | -27,128 |
| Net Income | $17,382 | $8,550 | $-4,938 | $-16,540 | $-27,128 |
| EPS Basic Total Ops | 0.22 | 0.11 | -0.07 | -0.24 | -0.40 |
| EPS Basic Continuous Ops | 0.22 | 0.11 | -0.07 | -0.24 | -0.40 |
| EPS Diluted Total Ops | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
| EPS Diluted Continuous Ops | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.05 | -0.07 | -0.27 | -0.40 |
| EBITDA(a) | $17,064 | $8,540 | $-4,571 | $-17,573 | $-25,958 |